Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients

Abstract

The bronchial epithelium is continuously exposed to a multitude of noxious challenges in inhaled air. Cellular contact with most damaging agents is reduced by the action of the mucociliary apparatus and by formation of a physical barrier that controls passage of ions and macromolecules. In conjunction with these defensive barrier functions, immunomodulatory cross-talk between the bronchial epithelium and tissue-resident immune cells controls the tissue microenvironment and barrier homeostasis. This is achieved by expression of an array of sensors that detect a wide variety of viral, bacterial, and nonmicrobial (toxins and irritants) agents, resulting in production of many different soluble and cell-surface molecules that signal to cells of the immune system. The ability of the bronchial epithelium to control the balance of inhibitory and activating signals is essential for orchestrating appropriate inflammatory and immune responses and for temporally modulating these responses to limit tissue injury and control the resolution of inflammation during tissue repair. In asthmatic patients abnormalities in many aspects of epithelial barrier function have been identified. We postulate that such abnormalities play a causal role in immune dysregulation in the airways by translating gene-environment interactions that underpin disease pathogenesis and exacerbation.

Epithelial folliculin enhances airway inflammation in aspirin‐exacerbated respiratory disease

“…When the epithelial layer is disturbed, uptake of allergens and viruses may trigger either allergic inflammation or toll‐like receptor‐dependent pathways . In addition, signal transduction cascades in HAECs are more likely to be dysregulated, affecting activation and differentiation of epithelial cells . In the present study, we demonstrated that eosinophils disrupted the expression of AJ and TJ in HAECs, which are comparable to the results of previous reports .…”

Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation

“…The respiratory tract is made of pseudostratified epithelium, comprising ciliated cells, mucus‐producing goblet cells and undifferentiated basal cells (Fig. ) . The mucosal layer contains mucins, defensins, IgA and antioxidants, which form an integral part of the innate immune response .…”

“…Multiprotein subunits [claudins, occludin, zona occludens (ZOs) and junctional adhesion molecules] comprise the respiratory TJs that regulate permeability, promote cell–cell adhesion and maintain barrier integrity . In asthmatic airways, claudin‐1, claudin‐4 and claudin‐18 are suppressed by the IL‐13/Th2 pathway, which results in increased paracellular leakiness and respiratory hyper‐responsiveness . Occludins and ZOs, particularly ZO‐1, are reduced in upper airway epithelial cells, permitting neutrophil activation and cytotoxic cytokine release, causing local tissue damage .…”

“…Recent findings suggest that both inherited and acquired defects at epithelial barrier surfaces permit enhanced allergen penetration, IgE sensitization and systemic T helper (Th)2 response . In addition, levels of regulatory T cells (Tregs) in the skin, gut and lung epithelia are diminished or ineffective at modulating the inflammatory response . When the barrier properties of the epidermal skin surface fail, there is increased epicutaneous absorption of environmental allergens and a dysregulated immune response that predisposes to development of food allergy and asthma .…”

Extracellular vesicles and asthma: A review of the literature

“…An estimated 235 million people are afflicted by asthma worldwide, but it is often underdiagnosed and undertreated . Both environmental and genetic factors are involved in the pathogenesis of asthma . The immunohistopathologic features of asthma include granulocytic and lymphocytic infiltration, mast cell activation and epithelial cell injury.…”